EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Comparison of Frozen Section and Final Pathology Results in Borderline Ovarian Tumors: A Retrospective Cohort Study

Isik Sozen, Zeliha Fusun Baba, Ilayda Aksoy, Gokce Nur Esen Topal, Gozde Sahin, Ilkbal Temel Yuksel iD

Diagnostics · 14.07.2026 · 16 (14) · 2185

DOI: 10.3390/diagnostics16142185 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Diagnostics, online erschienen am 14.07.2026. Verfasst von Isik Sozen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecologic Oncology, Başakşehir Çam and Sakura City Hospital, 34480 Istanbul, Turkey. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Borderline ovarian tumor (BOT) is an ovarian neoplasm of low malignant potential that lacks stromal invasion. The aim of this study was to compare intraoperative frozen section analysis (IFSA) findings with final pathology results in patients diagnosed with BOT on frozen sections and to identify risk factors associated with cancer.

Methods

This study included data from patients who underwent surgery for an ovarian mass between 2020 and 2024 and were diagnosed with BOT on IFSA. Demographic, obstetric, and clinical characteristics, as well as frozen section and final pathology findings, were recorded. The CAR, NLR, and PNI scores were calculated. Patients were grouped as premenopausal or postmenopausal and compared. Based on the final pathology report, patients were also classified as having BOT or cancer and compared.

Results

A total of 92 patients were included in the study, and 53 (57.6%) were postmenopausal. The prevalence of cancer was significantly higher in the postmenopausal group (p = 0.022). Final pathology revealed cancer in 11 patients (11.9%). Age group > 45 years (OR = 12.50) and serous subtype on IFSA (OR = 10.77) were significant risk factors for cancer detection. Cutoff values for distinguishing carcinoma from BOT were identified for CAR (≥1.75), NLR (≥2.64), and PNI (≤48.64).

Conclusions

In this study, the rate of invasive carcinoma on final pathology among patients diagnosed with BOT on IFSA was 11.9%. Age group > 45 years and serous subtype on IFSA were independent risk factors. The cutoff values for CAR, NLR, and PNI may support risk stratification for carcinoma.

Schlagwörter

Stichwörter der Autor:innen

borderline ovarian tumorcarcinomafrozen sectionovarian neoplasmsrisk factors

Autor:innen und Institutionen

  • Department of Gynecologic Oncology, Başakşehir Çam and Sakura City Hospital, 34480 Istanbul, Turkey.
  • Department of Pathology, Başakşehir Çam and Sakura City Hospital, 34480 Istanbul, Turkey.
  • Department of Obstetrics and Gynecology, Başakşehir Çam and Sakura City Hospital, 34480 Istanbul, Turkey.

ORCID-Profile: Ilkbal Temel Yuksel

Zitieren

APA

Sozen, I., Baba, Z. F., Aksoy, I., Topal, G. N. E., Sahin, G., & Yuksel, I. T. (2026). Comparison of Frozen Section and Final Pathology Results in Borderline Ovarian Tumors: A Retrospective Cohort Study. Diagnostics, 16(14), 2185. https://doi.org/10.3390/diagnostics16142185

Vancouver

Sozen I, Baba ZF, Aksoy I, Topal GNE, Sahin G, Yuksel IT. Comparison of Frozen Section and Final Pathology Results in Borderline Ovarian Tumors: A Retrospective Cohort Study. Diagnostics. 2026;16(14):2185. doi:10.3390/diagnostics16142185

BibTeX
@article{Sozen2026,
  author = {Sozen, Isik and Baba, Zeliha Fusun and Aksoy, Ilayda and Topal, Gokce Nur Esen and Sahin, Gozde and Yuksel, Ilkbal Temel},
  title = {Comparison of Frozen Section and Final Pathology Results in Borderline Ovarian Tumors: A Retrospective Cohort Study},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {14},
  pages = {2185},
  doi = {10.3390/diagnostics16142185}
}
Kostenlos starten →